RC98
RC98 is a monoclonal antibody targeting programmed cell death ligand 1 (PD-L1) and acts as a selective PD-L1 inhibitor. RC98 binds specifically to human and cynomolgus monkey PD-L1. RC98 blocks the interaction between PD-L1 and its receptor PD-1 to reverse T-cell inactivation mediated by PD-1/PD-L1 signaling. RC98 enhances the cytotoxic T-lymphocyte-mediated anti-tumor immune response against PD-L1-expressing tumor cells. RC98 can be used for the research of tumor immunity and solid tumors.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
Species Reactivity
Human
Parmacokinetics
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Cynomolgus monkeys (half female and half male)[1]
-
Dosage:15 mg/kg
-
Administration:i.v.; once weekly; 4 weeks
-
Result:Reached a mean peak PD-L1 receptor occupancy of 64.5% on CD3+ T cells within 24 h after the first infusion.
Showed reduced receptor occupancy after repeated dosing but maintained levels above background throughout testing.
Elevated anti-KLH IgM levels versus controls at 168 h, 336 h, and 504 h post-first dose.
Increased anti-KLH IgG levels versus controls at multiple time points post-first and last doses.
Induced sustained elevation of soluble PD-L1 with a strong correlation to serum RC98 concentrations.
遺伝子ID
アクセッション番号
Target
B7-H1/PD-L1/CD274
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
アプリケーション
ELISA, FACS, Functional assay
化学情報
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)